# A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting

> **NCT05094128** · — · RECRUITING · sponsor: **AbbVie** · enrollment: 352 (estimated)

## Conditions studied

- Axial Spondylarthritis (r-axSpA)

## Interventions

- **DRUG:** Upadacitinib

## Key facts

- **NCT ID:** NCT05094128
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-22
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 352 (ESTIMATED)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05094128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05094128, "A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05094128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*